. . . . . . . . . "RIDAURA (auranofin) is contraindicated in patients with a history of any of the following gold-induced disorders: anaphylactic reactions, necrotizing enterocolitis, pulmonary fibrosis, exfoliative dermatitis, bone marrow aplasia or other severe hematologic disorders." . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "RJarM6svpFCFXcqNEfgYVVE2LFf4E10ViQrRvKNASYheMNlOHRWNpz7yRJ6OTjurugpkjlocm2PekmC8PD1Wl0OBv85BMxw8gYuuFmU2VDujeZQtTuwZOjWrw+q3oyqHWAzcUaEkFJlY8UHv3wtnbXQ3rBM6tcKo5gzm9c4+umA=" . . "2021-08-23T19:00:30.000+02:00"^^ . . . . .